Lyell Immunopharma Inc (LYEL) — Cash Flow Reinvestment Rate
Lyell Immunopharma Inc (LYEL) has a Cash Flow Reinvestment Rate of 10.70x as of December 2019, reinvesting $422.43 Million (capex $16.05 Million plus investments $-406.39 Million) from operating cash flow of $39.47 Million. See LYEL FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Lyell Immunopharma Inc Cash Flow Reinvestment Rate (2019–2019)
Historical reinvestment intensity for Lyell Immunopharma Inc across 1 annual periods. For the full cash flow conversion analysis, see LYEL operating cash flow.
Annual Cash Flow Reinvestment Rate for Lyell Immunopharma Inc (2019–2019)
Year-by-year capital reinvestment analysis for Lyell Immunopharma Inc. See LYEL free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 10.70x | $422.43 Million | $39.47 Million | $16.05 Million | — |